Global Critical Care Diagnostics Market to reach USD 1.51 billion by 2026

Global Critical Care diagnostics Market Size study, by Type (Flow cytometry, Immunoproteins, Routine and special chemistry, Hematology, Coagulation test, Microbial Infectious diseases and Others), by End-user (Intensive care units, Emergency Rooms, Operating Rooms, Others) and Regional Forecasts 2019-2026
Product Code:  HALMD_30008312
Chapter 1.	Executive Summary  
1.1.	Market Snapshot
1.2.	Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Billion)
1.2.1.	Critical Care Diagnostic Market, by Type, 2017-2026 (USD Billion)
1.2.2.	Critical Care Diagnostic Market, by End-User, 2017-2026 (USD Billion)
1.2.3.	Critical Care Diagnostic Market, by Region, 2017-2026 (USD Billion)
1.3.	Key Trends
1.4.	Estimation Methodology
1.5.	Research Assumption
Chapter 2.	Global Critical Care Diagnostic Market Definition and Scope 
2.1.	Objective of the Study
2.2.	Market Definition & Scope
2.2.1.	Scope of the Study
2.2.2.	Industry Evolution
2.3.	Years Considered for the Study
2.4.	Currency Conversion Rates
Chapter 3.	Global Critical Care Diagnostic Market Dynamics	
3.1.	Critical Care Diagnostic Market Impact Analysis (2018-2026)
3.1.1.	Market Drivers
3.1.2.	Market Challenges
3.1.3.	Market Opportunities
Chapter 4.	Global Critical Care Diagnostic Market Analysis
4.1.	Porter’s 5 Force Model
4.1.1.	Bargaining Power of Suppliers
4.1.2.	Bargaining Power of Buyers
4.1.3.	Threat of New Entrants
4.1.4.	Threat of Substitutes
4.1.5.	Competitive Rivalry
4.1.6.	Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2.	PEST Analysis
4.2.1.	Political 
4.2.2.	Economical
4.2.3.	Social 
4.2.4.	Technological 
4.3.	Investment Adoption Model
4.4.	Analyst Recommendation & Conclusion
Chapter 5.	Global Critical Care Diagnostic Market, by Type
5.1.	Market Snapshot 
5.2.	Global Critical Care Diagnostic Market by Type, Performance - Potential Analysis
5.3.	Global Critical Care Diagnostic Market Estimates & Forecasts by Type, 2016-2026 (USD Billion)
5.4.	Critical Care Diagnostic Market, Sub Segment Analysis
5.4.1.	Flow Cytometry  
5.4.2.	Haematology
5.4.3.	Routine and special chemistry  
5.4.4.	Microbial and infectious diseases
5.4.5.	Immunoproteins 
5.4.6.	Coagulation test  
5.4.7.	Others
Chapter 6.	Global Critical Care Diagnostic Market, by End-User 
6.1.	Market Snapshot 
6.2.	Global Critical Care Diagnostic Market by End-User, Performance - Potential Analysis
6.3.	Global Critical Care Diagnostic Market Estimates & Forecasts by End-User, 2016-2026 (USD Billion)
6.4.	Critical Care Diagnostic Market, Sub Segment Analysis
6.4.1.	Emergency Rooms   
6.4.2.	Operating rooms   
6.4.3.	Intensive care units 
6.4.4.	Others
Chapter 7.	Global Critical Care Diagnostic Market, Regional Analysis
7.1.	Critical Care Diagnostic Market, Regional Market Snapshot 
7.2.	North America Critical Care Diagnostic Market 
7.2.1.	U.S. Critical Care Diagnostic Market
7.2.1.1.	Type breakdown estimates & forecasts, 2016-2026
7.2.1.2.	End-User breakdown estimates & forecasts, 2016-2026
7.2.2.	Canada Critical Care Diagnostic Market
7.3.	Europe Critical Care Diagnostic Market Snapshot
7.3.1.	U.K. Critical Care Diagnostic Market
7.3.2.	Germany Critical Care Diagnostic Market
7.3.3.	Rest of Europe Critical Care Diagnostic Market
7.4.	Asia-Pacific Critical Care Diagnostic Market Snapshot
7.4.1.	China Critical Care Diagnostic Market 
7.4.2.	India Critical Care Diagnostic Market 
7.4.3.	Japan Critical Care Diagnostic Market
7.4.4.	Rest of Asia Pacific Critical Care Diagnostic Market
7.5.	Latin America Critical Care Diagnostic Market Snapshot
7.5.1.	Brazil Critical Care Diagnostic Market
7.5.2.	Mexico Critical Care Diagnostic Market
7.6.	Rest of The World Critical Care Diagnostic Market
Chapter 8.	Competitive Intelligence
8.1.	Top Market Strategies
8.2.	Company Profiles
8.2.1.	Abbott Laboratories
8.2.1.1.	Overview
8.2.1.2.	Financial (Subject to Data Availability)
8.2.1.3.	Product Summary
8.2.1.4.	Recent Developments
8.2.2.	Alere, Inc. 
8.2.3.	Beckman Coulter, Inc.
8.2.4.	Becton Dickinson and Company, 
8.2.5.	Bayer AG 
8.2.6.	Siemens Healthineers 
8.2.7.	F. Hoffmann-La Roche Ltd.
8.2.8.	Bio-Rad Laboratories 
8.2.9.	BioMerieux, Inc. 
8.2.10.	Nova Biomedical
Chapter 9.	 Research Process
9.1.	Research Process
9.1.1.	Data Mining
9.1.2.	Analysis
9.1.3.	Market Estimation
9.1.4.	Validation
9.1.5.	Publishing
9.2.	Research Attributes
9.3.	Research Assumption

Global Critical Care diagnostics Market valued approximately USD 0.95 billion in 2018 is anticipated to grow with a healthy growth rate of more than 6.0% over the forecast period 2019-2026. Rising acceptance of these tests by patients and physicians and improvements in healthcare technologies are some factors triggering the growth of the critical care diagnostics market over the forecast period.
Key driving factors for the critical care diagnostics market are high prevalence of chronic diseases along with the technological advancements in critical care diagnostics products. For instance: According to British Heart Foundation, more than one fourth of the deaths in UK are due to CVD, accounting around 3.9 million deaths each year. There are 7 million people living with CVD in the U.K. Also, coronary heart diseases are the leading cause for deaths in U.K. and nearly one in six men and one in ten women die from coronary heart disease. CHD is responsible for around 73,000 deaths in the UK each year. In UK, CHD affects the aging population and around 23,000 people under the age of 75 die from CHD each year. In addition, the Fight Chronic Disease Organization estimates that in 2015, in United States around 133 million deaths are caused and disability due to chronic diseases. It is estimated that 45% Americans populations are suffering from at least one chronic disease. Since, critical care diagnostics tests allows clinicians to identify and detect organism accurately and helps to offer proper guidance to clinicians thereby, promoting the demand for critical care diagnostics tests over the forecast period. Furthermore, growing adoption of electronic health record (EHR) coupled with the telehealth services is offers lucrative growth prospects for the critical care diagnostics market. However, high cost associated with molecular diagnostics tools are expected to hinder the growth of the market during the forecast period.
On the basis of segmentation, the critical care diagnostics market is segmented into type and end-user. The type segment of global critical care diagnostics market is classified into flow cytometry, immunoproteins, routine and special chemistry, hematology, coagulation test, microbial and infectious diseases and others of which immunoproteins diagnostic test is also to dominate the market with largest share due to growing demand for accurate preventive healthcare services. On the basis of end-user segment, the market is classified into intensive care units, emergency rooms, operating rooms and others of which emergency rooms are anticipated to witness lucrative growth owing to the growing need for ER service as it offers initial acute care treatment and diagnosis to critically ill patients.

The regional analysis of critical care diagnostics market is considered for the key regions such as North America, Europe, Asia Pacific, Latin America and ROW. North America holds the leading position in critical care diagnostics market owing to the high research and development activities along with presence of well-established healthcare infrastructure. Whereas, Asia-Pacific is expected to emerge as the fastest growing region in terms of market share. The growth of Asia-Pacific region is witnessed owing to high prevalence of chronic diseases along with rising geriatric population. Also, improving healthcare infrastructure and services in rural areas is also expected to supplement the growth of Asia-Pacific region over the forecast period.

The leading market players included in this report are:
Abbott Laboratories
Alere, Inc.
Beckman Coulter, Inc.
Becton Dickinson and Company,
Bayer AG
Siemens Healthineers
F. Hoffmann-La Roche Ltd.
Bio-Rad Laboratories
BioMerieux, Inc.
Nova Biomedical

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type
Flow Cytometry
Microbial and Infectious Diseases
Routine and special chemistry
Hematology
Immunoproteins
Coagulation Test
Others

By End-user:
Emergency rooms
Intensive Care Units
Operating Rooms
Other End Users

By Regions:
North America
U.S.
Canada
Europe
UK
Germany
ROE
Asia Pacific
China
India
Japan
ROAPEC
LAMEA
Brazil
Mexico
ROW
Middle East & Africa

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026

Target Audience of the Global Critical Care diagnostics Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors


We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Full Name*

Business Email* (Please avoid generic email IDs such as gmail, yahoo)

Phone* (Please Affix Country Code)

Need specific market information? To get a customized report, please share your exact research requirements.



Loading…